Pharma: Swiss pharmaceutical CEO cautions that patients will bear the cost of tariffs on generic drugs proposed by Trump.
🚨 Sandoz CEO Richard Saynor highlights a critical issue: high U.S. tariffs on imported generic drugs may lead manufacturers to either hike prices or reduce supply. This could have significant implications for access to affordable medications! 💊💰 #Healthcare #GenericDrugs
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0